TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Sep 9, 4:02 PM ET

McAvoy David R. 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Sep 9, 2025

Insider Transaction Report

Form 4
Period: 2025-09-05
McAvoy David R.
EVP, Chief Legal Officer
Transactions
  • Purchase

    Ordinary Shares

    2025-09-05$18.86/sh+1,113$20,98813,027 total
Footnotes (1)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4